Results 131 to 140 of about 8,299 (247)

A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores

, 2015
Giorgio Fois, Nina Hobi, Edward Felder, Andreas Ziegler, Pika Miklavc, Paul Walther, Peter Radermacher, Thomas Haller, Paul Dietl   +8 more
openalex   +2 more sources

Ambroxol

Reactions Weekly, 2007
openaire   +3 more sources

Stability-Indicating HPTLC Method for Simultaneous Estimation of Amoxicillin Trihydrate and Ambroxol Hydrochloride in Bulk and Pharmaceutical Dosage Form

, 2013
Sneha R. Tawargeri
openalex   +1 more source

Effects of Ambroxol on the Transfer of Ceftizoxime into the Ethmoid Cell Mucosa.

, 1997
Takaki Miwa, Keiko Kita, Akiko TAMORI, Akiko Nakahashi, Makoto Sakumoto, Yasuyuki Kimura, Yohzo OKABE, Ikuo Nagayama, Mitsuru Furukawa   +8 more
openalex   +2 more sources

The ANeED study: Ambroxol in new and early dementia with Lewy bodies [PDF]

, 2020
Arvid Rongve, Elin Holst‐Larsen, Stina Steingildra, Charalampos Tzoulis, Kristoffer Haugarvoll, Kjell‐Morten Myhr, Dag Aarsland   +6 more
openalex   +1 more source

[Retracted] Study on the Efficacy and Safety of Ambroxol Combined with Methylprednisolone in Patients with Acute Lung Injury [PDF]

, 2021
Weiwei Su, Qinglian Dong, Fangfang Jiao
openalex   +1 more source

Ambroxol hydrochloride and clenbuterol hydrochloride oral solution versus ambroxol hydrochloride injection for pediatric lower respiratory tract infection with mucoid sputum: a multicenter, non-randomized observational study in China. [PDF]

Transl Pediatr
Chen C, Hu B, Liu E, Ma J, Liu C, Dong X, Zi H, Hao C, Lin R, Zheng X, Li B, Chen F, Fang M, Tian W, Zhuo Z, Zhao D, Chen Z, Zheng Y, Zheng J, Yin Y, Tang Q, Wu L, Gu L, Wu J, He L, Ai T, Liu H, Han Z, Mo Y, Tian Z, Lu Q, Zou Y.   +31 more
europepmc   +1 more source

CLINICAL OUTCOMES OF AMBROXOL HYDROCHLORIDE IN INFANTS WITH SECRETORY OTITIS MEDIA

chen liwen, Minghao, Jun Zhang, MD
openalex   +1 more source

Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1^-/-SNCA^A53T double mutant mouse model of Parkinson's disease. [PDF]

Acta Pharmacol Sin
Franck L, Valek L, Hahnefeld L, Trautmann S, Angioni C, Weyer MP, Thomas D, Gurke R, Wittig I, Geisslinger G, Tegeder I.   +10 more
europepmc   +1 more source

Photopatch testing [PDF]

, 2011
A Barbaud, A Barbaud, A Barbaud, A Bryden, A Darvay, A Goossens, A Katsarou, A Kerr, A Lee, A Waters, B Berne, B Emmert, B Fernández-Jorge, B Ljunggren, C Duguid, C LeCoz, C Lovell, D Bruynzeel, D Karimian-Teherani, D Serra, D Shaw, E Due, E Durbize, E Rodríguez, E Yoshimoto, F Leonard, G Murphy, H Möller, H Oliveira, J Cardoso, J Cuadra-Oyanguren La, J Vilaplana, K Andersen, L Scalf, M Avenel-Audrun, M Bruze, M Canelas, M Gonçalo, M Gonçalo, M Gonçalo, M Gonçalo, M Hindsén, M Jeanmougin, M Kimura, M Singh, N Curr, N Fujimoto, N Neumann, N Neumann, O Lasa Elgezua, P Andrade, P Beattie, P Collins, P Pigatto, P Pigatto, P Stoebner, P Varela, R Bakkum, R Batchelor, R Diaz, S Gonçalo, S Schauder, T Hariva, T Horio, T Zeeli, V Devleeschouwer, V Madan, V Torres, V Vachiramon, Y Kurumajin   +69 more
core   +1 more source